Aggressive Behavior in Schizophrenia: Relationship to Age of Onset and Cortical Atrophy

References

• Aldegunde M., Miguez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. DSM-III: Diagnostic and Statistical Manual of Mental Disorders (3rd ed.). APA, Washington, DC 1980
   Google Scholar
• Andreasen N. C., Smith M. R., Jacoby C. G., Dennert J. W., Olsen S. A. Ventricular enlargement in schizophrenia: Definition and prevalence. American Journal of Psychiatry 1982; 139: 292–296
   PubMed Web of Science ®Google Scholar
• Andreasen N. C. Positive vs. negative schizophrenia: A critical evaluation. Schizophrenia Bulletin 1985; 11: 380–389
   PubMed Web of Science ®Google Scholar
• Arregui A., MacKay A. V. P., Iversen L. L., Spokes E. G. S. Reduction of angiotensinconverting enzyme in substantia nigra in early onset schizophrenia. New England Journal of Medicine 1979; 300: 502–503
   PubMed Web of Science ®Google Scholar
• Asberg M., Traskman L., Thoren P. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor. Archives of General Psychiatry 1976; 33: 1193–1197
   PubMed Web of Science ®Google Scholar
• Bach-y-Rita G., Lion J. R., Climent C. E. Episodic dyscontrol: a study of 130 violent patients. American Journal of Psychiatry 1971; 127: 1473–1478
   PubMed Web of Science ®Google Scholar
• Chase L. S., Silverman S. Prognostic criteria in schizophrenia. A critical survey of the literature. American Journal of Psychiatry 1941; 98: 360–368
   Google Scholar
• Craig T. J. An epidemiologic study of problems associated with violence among psychiatric inpatients. American Journal of Psychiatry 1982; 139: 1262–1266
   PubMed Web of Science ®Google Scholar
• Crow T. J. Two syndromes in schizophrenia. Trends in Neurosciences 1982; 5: 351–354
   Google Scholar
• Eaton W. E. Epidemiology of schizophrenia. Epidemiological Reviews 1985; 7: 105–126
   PubMed Web of Science ®Google Scholar
• Ferrier I. N., Cotes P. M., Crow T. J., Johnstone E. C. Gonadotrophin secretion abnormalities in chronic schizophrenia. Psychological Medicine 1982; 12: 263–273
   PubMed Web of Science ®Google Scholar
• Forel O. L. Le prognostic dans la pratique psychiatrique, son application au cas de schizophrenie. Schweizerische Archives fuer Neurologie und Psychiatrie 1931; 27: 250–258
   Google Scholar
• Goldberg E., Costa L. D. Hemispheric differences in the acquisition and use of descriptive systems. Brain & Language 1981; 14: 144–173
   PubMed Web of Science ®Google Scholar
• Johnstone E. C., Crow T. J., Frith C. D., Husband J., Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976; 2: 924–926
   PubMed Web of Science ®Google Scholar
• Johnstone E. C., Owens D. G. C., Bydder G. M., Cotler N., Crow T. J., Frith C. D. The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates. Psychological Medicine 1989; 19: 91–103
   PubMed Web of Science ®Google Scholar
• Kaplan H. I., Sadock B. J. Modern synopsis of comprehensive textbook of psychiatry/IV. 4th Edition. Williams & Wilkins, Baltimore 1985; 194–225
   Google Scholar
• Kay S. R., Murrill L. M. Predicting outcome of schizophrenia: significance of symptom profiles and outcome dimensions. Comprehensive Psychiatry 1990; 31: 91–102
   PubMed Web of Science ®Google Scholar
• Kay S. R., Fiszbein A., Opler L. A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987; 13: 261–276
   PubMed Web of Science ®Google Scholar
• Kay S. R., Opler L. A., Fiszbein A. Positive and Negative Syndrome Scale (PANSS). Multi-Health Systems Inc, Toronto, (in press)
   Google Scholar
• Kay S. R., Opler L. A., Lindenmayer J. P. Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenics. Psychiatry Research 1988; 23: 99–110
   PubMed Web of Science ®Google Scholar
• Kraepelin E. Dementia praecox and paraphrenia. E & S. Livingston, Edinburgh 1919
   Google Scholar
• Krakowski M. I., Convit A., Jaeger J., Lin S., Volavka J. Neurological impairment in violent schizophrenic inpatients. American Journal of Psychiatry 1989; 146: 849–853
   PubMed Web of Science ®Google Scholar
• Langfeldt G. Prognosis in schizophrenia and factors influencing course of disease: katamnestic study, including individual reexaminations in 1936 with some considerations regarding diagnosis, pathogenesis and therapy. Acta Psychiatrica et Neurologica 1937; 13: 1–8, (suppl)
   Google Scholar
• Lewis D. O., Shanok S. S., Grant M. Homicidally aggressive young children: neuropsychiatric and experiential correlates. American Journal of Psychiatry 1983; 140: 148–153
   PubMed Web of Science ®Google Scholar
• Lewis D. O., Shanok S. S., Pincus J. H. Violent juvenile delinquents: psychiatric. neurological, psychological and abuse factors. Journal of the American Academy of Child Psychiatry 1979; 18: 307–319
   PubMedGoogle Scholar
• MacKay A. V. P., Iversen L. L., Rossor M., Spokes E., Bird E., Arregui A., Creese I., Snyder S. H. Increased brain dopamine and dopamine receptors in schizophrenia. Archives of General Psychiatry 1982; 39: 991–997
   PubMed Web of Science ®Google Scholar
• Muehlbauer H. D. Human aggression and the role of central serotonin. Pharmacopsychiatrie 1985; 18: 218–221
   PubMed Web of Science ®Google Scholar
• Nieto D., Escobar A. Major Psychoses. Pathology of the nervous system, J. Minckler. McGraw-Hill, New York 1972; 2654–2665
   Google Scholar
• Ninan P. T., Van Kammen D. P., Scheinin M., Linnoila M., Bunney W. E., Goodwin F. K. CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. American Journal of Psychiatry 1984; 141: 566–569
   PubMed Web of Science ®Google Scholar
• Overall J. E., Gorham D. R. The Brief Psychiatric Rating Scale. Psychological Report 1962; 10: 799–812
   Web of Science ®Google Scholar
• Payne R. W. Cognitive abnormalities. Handbook of abnormal psychology, H. J. Eysenck. Pitman Medical Press, London 1972
   Google Scholar
• Rabins P., Pearlson G., Jayaram G., Steele C., Tune L. Increased ventricle-to-brain ratio in late-onset schizophrenia. American Journal of Psychiatry 1987; 144: 1216–1218
   PubMed Web of Science ®Google Scholar
• Roy A., DeJong J, Linnoila M. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Archives of General Psychiatry 1989; 46: 609–612
   PubMed Web of Science ®Google Scholar
• Rupp C., Fletcher E. K. Five to ten years follow-up study of 641 schizophrenic cases. American Journal of Psychiatry 1940; 96: 877–882
   Google Scholar
• Sandyk K., Kay S. K. Drug-induced Parkinsonism: relationship to age at onset of schizophrenia. Functional Neurology 1991a; 6: 151–157
   PubMedGoogle Scholar
• Sandyk R., Kay S. R. Pineal calcification in schizophrenia: relationship to age of onset and tardive dyskinesia. Schizophrenia Research 1991b; 5: 85–86
   PubMed Web of Science ®Google Scholar
• Sandyk R., Kay S. R. Subjective awareness of abnormal involuntary movements in schizophrenia: relationship to age at onset. International Journal of Neuroscience, in press
   Google Scholar
• Shader R. I., Jackson A. H., Harmatz J. S. Patterns of violent behavior among schizophrenic inpatients. Diseases of the Nervous System 1977; 38: 13–16
   PubMedGoogle Scholar
• Shelton R. C., Karson K. N., Doran A. R., Pickar D., Bigelow L. B., Weinberger D. R. Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect. American Journal of Psychiatry 1988; 145: 154–163
   PubMed Web of Science ®Google Scholar
• Spitzer R. L., Endicott J. E., Robins E. Research Diagnostic Criteria (RDC) for a Select group of Functional Disorders. New York State Psychiatric Institute. Bimetrics Research, New York 1978
   Google Scholar
• Spokes E. G. S., Garrett N. J., Rossor M. N., Iversen L. I. Distribution of GABA in postmortem brain tissue from control, psychotic and Huntington's chorea subjects. Journal of the Neurological Sciences 1980; 48: 303–313
   PubMed Web of Science ®Google Scholar
• Stevens J. Neuropathology of schizophrenia. Archives of General Psychiatry 1982; 39: 1131–1139
   PubMed Web of Science ®Google Scholar
• Sugden D., Morris R. D. Changes in regional brain levels of tryptophan. 5-hydroxytryptamine, 5-hydroxyindoleacetic acid, dopamine and noradrenaline after pinealectomy in the rat. Journal of Neurochemistry 1979; 32: 1593–1594
   PubMed Web of Science ®Google Scholar
• Synek V., Reuben J. R. The ventricular brain ratio using planimetric measurements of EMI scans. British Journal of Radiology 1976; 49: 233–237
   PubMed Web of Science ®Google Scholar
• Tsuang M. T., Winokur G. Criteria for subtyping schizophrenia. Archives of General Psychiatry 1974; 31: 43–47
   PubMed Web of Science ®Google Scholar
• Van Praag H. M. CSF-5HIAA and suicide in non-depressed schizophrenics. Lancet 1983; 1: 977–978
   PubMedGoogle Scholar
• Wechsler D. WAIS-R Manual. Psychological Corporation, New York 1981
   Google Scholar
• Wyatt R. J., Potkin S. G., Kleinman J. E. The schizophrenia syndrome: examples of biological tools for subclassification. Journal of Nervous and Mental Disease 1981; 169: 100–112
   PubMed Web of Science ®Google Scholar